1tdl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1tdl" size="450" color="white" frame="true" align="right" spinBox="true" caption="1tdl, resolution 1.8&Aring;" /> '''Structure of Ser130Gl...)
Line 1: Line 1:
-
[[Image:1tdl.jpg|left|200px]]<br /><applet load="1tdl" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1tdl.jpg|left|200px]]<br /><applet load="1tdl" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1tdl, resolution 1.8&Aring;" />
caption="1tdl, resolution 1.8&Aring;" />
'''Structure of Ser130Gly SHV-1 beta-lactamase'''<br />
'''Structure of Ser130Gly SHV-1 beta-lactamase'''<br />
==Overview==
==Overview==
-
A bacterial response to the clinical use of class A beta-lactamase, inhibitors such as tazobactam and clavulanic acid is the expression of, variant beta-lactamases with weaker binding affinities for these, mechanism-based inhibitors. Some of these inhibitor-resistant variants, contain a glycine mutation at Ser130, a conserved active site residue, known to be adventitiously involved in the inhibition mechanism. The, crystallographic structure of a complex of tazobactam with the Ser130Gly, variant of the class A SHV-1 beta-lactamase has been determined to 1.8 A, resolution. Two reaction intermediates are observed. The primary, intermediate is an acyclic species bound to the reactive Ser70. It is, poorly primed for catalytic hydrolysis because its ester carbonyl group is, completely displaced from the enzyme's oxyanion hole. A smaller fraction, of the enzyme contains a Ser70-bound aldehyde resulting from hydrolytic, loss of the triazoyl-sulfinyl amino acid moiety from the primary species., This first structure of a class A beta-lactamase lacking Ser130, the side, chain of which functions in beta-lactam binding and possibly in catalysis, gives crystallographic evidence that the acylation step of beta-lactam, turnover can occur without Ser130. Unexpectedly, the crystal structure of, the uncomplexed Ser130Gly enzyme, also determined to 1.8 A resolution, shows that a critical Glu166-activated water molecule is missing from the, catalytic site. Comparison of this uncomplexed variant with the wild-type, structure reveals that Ser130 is required for orienting the side chain of, Ser70 and ensuring the hydrogen bonding of Ser70 to both Lys73 and the, catalytic water molecule.
+
A bacterial response to the clinical use of class A beta-lactamase inhibitors such as tazobactam and clavulanic acid is the expression of variant beta-lactamases with weaker binding affinities for these mechanism-based inhibitors. Some of these inhibitor-resistant variants contain a glycine mutation at Ser130, a conserved active site residue known to be adventitiously involved in the inhibition mechanism. The crystallographic structure of a complex of tazobactam with the Ser130Gly variant of the class A SHV-1 beta-lactamase has been determined to 1.8 A resolution. Two reaction intermediates are observed. The primary intermediate is an acyclic species bound to the reactive Ser70. It is poorly primed for catalytic hydrolysis because its ester carbonyl group is completely displaced from the enzyme's oxyanion hole. A smaller fraction of the enzyme contains a Ser70-bound aldehyde resulting from hydrolytic loss of the triazoyl-sulfinyl amino acid moiety from the primary species. This first structure of a class A beta-lactamase lacking Ser130, the side chain of which functions in beta-lactam binding and possibly in catalysis, gives crystallographic evidence that the acylation step of beta-lactam turnover can occur without Ser130. Unexpectedly, the crystal structure of the uncomplexed Ser130Gly enzyme, also determined to 1.8 A resolution, shows that a critical Glu166-activated water molecule is missing from the catalytic site. Comparison of this uncomplexed variant with the wild-type structure reveals that Ser130 is required for orienting the side chain of Ser70 and ensuring the hydrogen bonding of Ser70 to both Lys73 and the catalytic water molecule.
==About this Structure==
==About this Structure==
-
1TDL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae] with MA4 and EPE as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1TDL OCA].
+
1TDL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae] with <scene name='pdbligand=MA4:'>MA4</scene> and <scene name='pdbligand=EPE:'>EPE</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TDL OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Klebsiella pneumoniae]]
[[Category: Klebsiella pneumoniae]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Bethel, C.R.]]
+
[[Category: Bethel, C R.]]
-
[[Category: Bonomo, R.A.]]
+
[[Category: Bonomo, R A.]]
-
[[Category: Knox, J.R.]]
+
[[Category: Knox, J R.]]
[[Category: Sun, T.]]
[[Category: Sun, T.]]
[[Category: EPE]]
[[Category: EPE]]
Line 26: Line 26:
[[Category: penicillinase]]
[[Category: penicillinase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 03:10:59 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:12:25 2008''

Revision as of 13:12, 21 February 2008


1tdl, resolution 1.8Å

Drag the structure with the mouse to rotate

Structure of Ser130Gly SHV-1 beta-lactamase

Overview

A bacterial response to the clinical use of class A beta-lactamase inhibitors such as tazobactam and clavulanic acid is the expression of variant beta-lactamases with weaker binding affinities for these mechanism-based inhibitors. Some of these inhibitor-resistant variants contain a glycine mutation at Ser130, a conserved active site residue known to be adventitiously involved in the inhibition mechanism. The crystallographic structure of a complex of tazobactam with the Ser130Gly variant of the class A SHV-1 beta-lactamase has been determined to 1.8 A resolution. Two reaction intermediates are observed. The primary intermediate is an acyclic species bound to the reactive Ser70. It is poorly primed for catalytic hydrolysis because its ester carbonyl group is completely displaced from the enzyme's oxyanion hole. A smaller fraction of the enzyme contains a Ser70-bound aldehyde resulting from hydrolytic loss of the triazoyl-sulfinyl amino acid moiety from the primary species. This first structure of a class A beta-lactamase lacking Ser130, the side chain of which functions in beta-lactam binding and possibly in catalysis, gives crystallographic evidence that the acylation step of beta-lactam turnover can occur without Ser130. Unexpectedly, the crystal structure of the uncomplexed Ser130Gly enzyme, also determined to 1.8 A resolution, shows that a critical Glu166-activated water molecule is missing from the catalytic site. Comparison of this uncomplexed variant with the wild-type structure reveals that Ser130 is required for orienting the side chain of Ser70 and ensuring the hydrogen bonding of Ser70 to both Lys73 and the catalytic water molecule.

About this Structure

1TDL is a Single protein structure of sequence from Klebsiella pneumoniae with and as ligands. Active as Beta-lactamase, with EC number 3.5.2.6 Full crystallographic information is available from OCA.

Reference

Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant., Sun T, Bethel CR, Bonomo RA, Knox JR, Biochemistry. 2004 Nov 9;43(44):14111-7. PMID:15518561

Page seeded by OCA on Thu Feb 21 15:12:25 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools